No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
KRYS240816C210000
- 15.98
- +2.68+20.15%
15min DelayClose Jul 23 12:39 ET
15.98High14.60Low
14.60Open13.30Pre Close15 Volume1.41K Open Interest210.00Strike Price23.34KTurnover72.62%IV8.98%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry15.98Extrinsic Value100Contract SizeAmericanOptions Type0.5162Delta0.0103Gamma14.25Leverage Ratio-0.3345Theta0.0617Rho7.36Eff Leverage0.2134Vega
Intraday
- 5D
- Daily
News
Unusual Options Activity: KMB, BA and Others Attract Market Bets, KMB V/OI Ratio Reaches 183.3
Cystic Fibrosis Market Is Projected to Boost by 2034, Predicts DelveInsight | Key Companies - Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal Biotech, Aridis Pharmaceuticals, BiomX, Inc., Boehringer Ingelheim
Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $204
Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $4,200 Today
How Is The Market Feeling About Krystal Biotech?
Comments
The strong revenue growth is mirrored in the share price gain. Despite the strong run, top performers like Krystal Biotech can continue winning for decades. The stock's recent performance improvement may suggest real business momentum.
1
High insider ownership at Krystal Biotech implies management's alignment with shareholders. Yet, no insider transactions in the last three months and significant share selling over the past year are concerning.
Analysts' optimism soars as they forecast Krystal Biotech to break even soon, given its massive projected annual growth rate of 68%. The firm's debt-free operation, unusual in loss-making biotech companies, lowers investment risk.
Market rewards Krystal Biotech's significant revenue growth despite recent stock price decline. Bullish sentiment suggests ongoing positive trend, irrespective of the current drop.
Read more